Geographic Distribution, Foreign was the largest of Staar Surgical Co’s 2 reported lines in fiscal 2026, at $171.62M — 88% of $194.18M.
| Geography | FY 2016 | FY 2017 | FY 2018 | FY 2020 | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Geographic Distribution, Foreign | $266.73M | $252.19M | $171.62M | |||||||
| Geographic Distribution, Domestic | $17.22M | $19.90M | $22.56M | |||||||
| Total | $283.95M | $272.09M | $194.18M |
In fiscal 2026, which ended January 2, 2026, the 2 regions Staar Surgical Co reported in this breakdown added up to $194.18M. That is less than the $239.44M in its breakdown by revenue line, so these regions do not account for all of its revenue that year. Geographic Distribution, Foreign was the largest region, at $171.62M or 88.4% of the total, followed by Geographic Distribution, Domestic ($22.56M, 11.6%).
Compared with fiscal 2024, the latest earlier year reported, Geographic Distribution, Domestic grew the fastest, rising 13.4% to $22.56M. Geographic Distribution, Foreign fell the most, down 31.9% to $171.62M.
This breakdown covers 10 fiscal years between 2016 and 2026, as reported in Staar Surgical Co's annual filings.
Non Consignment Sales was the largest of Staar Surgical Co’s 2 reported lines in fiscal 2026, at $178.99M — 75% of $239.44M.
| Sales Category Axis | FY 2016 | FY 2017 | FY 2018 | FY 2020 | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Non Consignment Sales | $301.16M | $293.57M | $178.99M | |||||||
| Consignment Sales | $21.25M | $20.33M | $60.45M | |||||||
| Total | $322.42M | $313.90M | $239.44M |
In fiscal 2026, which ended January 2, 2026, the 2 revenue lines Staar Surgical Co reported in this breakdown added up to $239.44M. That was down 23.7% from $313.90M in fiscal 2024, the latest earlier year this breakdown was reported. Non Consignment Sales was the largest revenue line, at $178.99M or 74.8% of the total, followed by Consignment Sales ($60.45M, 25.2%).
Compared with fiscal 2024, the latest earlier year reported, Consignment Sales grew the fastest, rising 197.4% to $60.45M. Non Consignment Sales fell the most, down 39.0% to $178.99M. Over fiscal 2023 to 2026, revenue across these revenue lines went from $322.42M to $239.44M, a compound annual decline of 9.4%. Non Consignment Sales' share of the total fell from 93.4% to 74.8% over the same years.
This breakdown covers 10 fiscal years between 2016 and 2026, as reported in Staar Surgical Co's annual filings.
Implantable Collamer Lenses was the largest of Staar Surgical Co’s 3 reported lines in fiscal 2017, at $68.33M — 75% of $90.61M.
| Products and Services | FY 2010 | FY 2011 | FY 2012 | FY 2014 | FY 2015 | FY 2016 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|---|
| Implantable Collamer Lenses | $44.13M | $44.05M | $51.54M | $59.11M | $68.33M | |||
| Intraocular Lenses | $24.15M | $24.34M | $19.86M | $19.71M | $17.26M | |||
| Other Surgical Products | $3.93M | $6.60M | $5.72M | $3.62M | $5.03M | |||
| Total | $72.22M | $74.99M | $77.12M | $82.43M | $90.61M |
In fiscal 2017, which ended December 29, 2017, the 3 revenue lines Staar Surgical Co reported in this breakdown added up to $90.61M. That was up 9.9% from $82.43M in fiscal 2016. Implantable Collamer Lenses was the largest revenue line, at $68.33M or 75.4% of the total, followed by Intraocular Lenses ($17.26M, 19.0%) and Other Surgical Products ($5.03M, 5.5%). Together, the two largest revenue lines made up 94.5% of this total.
Compared with fiscal 2016, Other Surgical Products grew the fastest, rising 39.1% to $5.03M. Intraocular Lenses fell the most, down 12.4% to $17.26M. Over fiscal 2014 to 2017, revenue across these revenue lines went from $72.22M to $90.61M, a compound annual growth rate of 7.9%. Implantable Collamer Lenses' share of the total rose from 61.1% to 75.4% over the same years.
This breakdown covers every fiscal year from 2010 to 2017, as reported in Staar Surgical Co's annual filings.
Staar Surgical Co (STAA) breaks its revenue down by region and revenue line. In fiscal 2026, its largest region was Geographic Distribution, Foreign, with $171.62M or 88.4% of the total, followed by Geographic Distribution, Domestic at $22.56M (11.6%).
Geographic Distribution, Foreign was Staar Surgical Co's largest region in fiscal 2026, with $171.62M in revenue, 88.4% of the $194.18M reported across its 2 regions.
Non Consignment Sales was Staar Surgical Co's largest revenue line in fiscal 2026, with $178.99M in revenue, 74.8% of the $239.44M reported across its 2 revenue lines.
Of the Staar Surgical Co revenue lines reported in both fiscal 2016 and fiscal 2017, and making up at least 2% of the total, Other Surgical Products grew the fastest, rising 39.1% from $3.62M to $5.03M.
Every figure is taken from Staar Surgical Co's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by region covers fiscal 2016 to 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.